Hainan Huluwa Pharmaceutical Group released a summary of the 2024 semi-annual report. During the reporting period, the company achieved revenue of 0.847 billion yuan, a decrease of 7.36% year-on-year; the net income attributable to shareholders of the listed company was 78.7516 million yuan, an increase of 28.33% year-on-year; and the basic earnings per share was 0.20 yuan.
葫芦娃：2024年上半年净利润同比增长28.33%
Hainan Huluwa Pharmaceutical Group: The net income in the first half of 2024 increased by 28.33% year-on-year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated